Actively Recruiting
Video Capsule Examination in Patients With Lynch Syndrome
Led by Royal Marsden NHS Foundation Trust · Updated on 2024-12-05
25
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
Sponsors
R
Royal Marsden NHS Foundation Trust
Lead Sponsor
K
King's College London
Collaborating Sponsor
AI-Summary
What this Trial Is About
Surveillance for colorectal cancer (CRC) in patients predisposed to develop CRC during their lifetime has been impacted by access to colonoscopy suites and endoscopy specialists in the past couple of years. An alternative method, namely the colon capsule, has been proposed, however this investigation is time consuming for the clinician and the images require up to one hour (30-60 minutes) reading to issue a result. The investigators propose to obtain images from paired colonoscopies and colon capsules with the purpose of developing an AI algorithm which could aid the clinicians in reading the colon and expand access to this investigation. The main aim of the study is to determine whether it is possible to obtain usable paired images from patients with Lynch and other cancer predisposition syndromes. This will depend on the willingness of the patients to take part in the study and the technical ability of obtaining data from paired images of colonoscopies and colon capsule. At recruitment, participants will undergo a colon capsule investigation, followed by a routine colonoscopy as per their normal standard of care. Paired endoscopic images from colonoscopies and colon capsules will be collected and anonymised data will be accessed by the bioinformatician for analysis. If the study will be successful in reaching the primary endpoint, further trials will be opened, allowing for a larger population to be included and to obtain more robust data, which eventually can lead to validated AI algorithms and application of computer-aided video-capsules examination as a screening tool in at-risk population.
CONDITIONS
Official Title
Video Capsule Examination in Patients With Lynch Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over the age of 18 years old with no active cancer
- No previous resection of the colon and/or rectum
- Carriers of a pathogenic or likely pathogenic variant in cancer-predisposition genes including Lynch syndrome (MLH1, MSH2, MSH6, PMS2), APC (FAP), biallelic MUTYH, STK11 (Peutz-Jeghers), PTEN, CDH1, CHEK2, TP53, BMPR1A, and SMAD4 (Juvenile polyposis syndrome)
- Able to consent to the study and undergo colonoscopy
You will not qualify if you...
- Extensive surgery causing high risk of video-capsule blockage or narrowing of the bowel
- Previous radiation to the abdomen or pelvis increasing risk of small bowel obstruction
- Carriers of variants with reduced penetrance or uncertain significance as determined by a geneticist
- Patients with performance status 3 or 4 and/or mobility issues
- Pregnancy
- Having a pacemaker or internal electro-medical device such as artificial heart valve or cochlear implant
- Insulin-dependent diabetes
- Patients requiring deep sedation for colonoscopy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Royal Marsden NHS Foundation Trust
London, (Select), United Kingdom, SW3 6JJ
Actively Recruiting
Research Team
E
Elena Cojocaru, MD
CONTACT
L
Lydia Taylor, RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here